✦ LIBER ✦

Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial

✍ Scribed by Uwe Zeymer; Hans-Richard Arntz; Bernd Mark; Stephan Fichtlscherer; Gerald Werner; Ralph Schöller; Ralf Zahn; Frank Diller; Harald Darius; Thorsten Dill; Kurt Huber

Book ID: 113037160
Publisher: Springer
Year: 2011
Tongue: English
Weight: 380 KB
Volume: 101
Category: Article
ISSN: 1861-0684
DOI: 10.1007/s00392-011-0393-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TCT-467: Safety and Efficacy Of High-Dos

TCT-467: Safety and Efficacy Of High-Dose Clopidogrel Loading In Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 208 KB

AS-255: Efficacy and Safety of High Load

AS-255: Efficacy and Safety of High Loading Dose of Clopidogrel (600 mg) in Asian Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents

✍ Cheol Ung Choi; Seung Woon Rha; Kanhaiya Lal Poddar; Kang Yin Chen; Yong Jian Li 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Randomized Trial of High Loading Dose of

Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary Intervention: Results From the ARMYDA-2 (Antiplatelet therapy for Reduction of Myocardial Damage during Angioplasty) Study

✍ G. Patti; G. Colonna; V. Pasceri; L.L. Pepe; A. Montinaro; G. Di Sciascio 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Impact of anemia in patients with acute

Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: Analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial

✍ E. Nikolsky; E.D. Aymong; A. Halkin 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 39 KB

A randomized, placebo-controlled trial t

A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the TIMI 37 trial

✍ David A. Morrow; Chaim M. Brickman; Sabina A. Murphy; Kenneth Baran; Ricardo Kra 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 258 KB

A Randomized, Double-Blind, Placebo-Cont

A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Intravenous MCC-135 as an Adjunct to Primary Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction: Rationale and Design of the Evaluation of MCC-135 for Left Ventricular Salvage in Acute MI (EVOLVE) Study

✍ Ik-Kyung Jang; Veronica Pettigrew; Michael H. Picard; Peter R. Kowey; Valentin D 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 219 KB